Data as of Mar 07
| +0.17 / +1.17%|
The 7 analysts offering 12-month price forecasts for NxStage Medical Inc have a median target of 17.00, with a high estimate of 21.00 and a low estimate of 12.00. The median estimate represents a +16.12% increase from the last price of 14.64.
The current consensus among 9 polled investment analysts is to Buy stock in NxStage Medical Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.